1 heptadecanoyl 2 hydroxy sn glycero 3 phosphate

Manufactured by Avanti Polar Lipids

Sourced in United States

1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphate is a phospholipid compound with a heptadecanoyl (C17) fatty acid chain and a hydroxyl group. It serves as a structural component in lipid membranes and bilayers.

Automatically generated - may contain errors

Lab products found in correlation

1 10z heptadecenoyl sn glycero 3 phosphoethanolamine, by Avanti Polar Lipids (1 mentions) Acetonitrile, by Avantor (1 mentions) Methanol, by Avantor (1 mentions) Chloroform hplc grade, by Avantor (1 mentions) N hexane, by Avantor (1 mentions) 1 2 dimyristoyl sn glycero 3 phosphocholine, by Avanti Polar Lipids (1 mentions) 1 2 dimyristoyl sn glycero 3 phosphoethanolamine, by Avanti Polar Lipids (1 mentions) 1 2 dimyristoyl sn glycero 3 phosphate, by Avanti Polar Lipids (1 mentions) 1 2 dimyristoyl sn glycero 3 phospho l serine, by Avanti Polar Lipids (1 mentions) 1 nonadecanoyl 2 hydroxy sn glycero 3 phosphocholine, by Avanti Polar Lipids (1 mentions) 1 my ristoyl 2 hydroxy sn glycero 3 phosphoethanolamine, by Avanti Polar Lipids (1 mentions)

2 protocols using 1 heptadecanoyl 2 hydroxy sn glycero 3 phosphate

Lipid Extraction and Characterization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

Reagent-grade chemicals and HPLC-grade solvents were purchased from major commercial suppliers (Fisher Scientific, Hampton, NH, USA, and Sigma Aldrich, St. Louis, MO, USA). 1,2-Dipalmitoyl-sn-glycero-3-phospho-N-methylethanolamine (PME) was purchased from Santa Cruz Biotech (Santa Cruz, CA, USA), and 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-phosphocholine (LPC(17:1)), 1-(10Z-heptadecenoyl)-sn-glycero-3-phosphoethanolamine (LPE(17:1)), 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-phospho-(1’-myo-inositol) (LPI(17:1)), and 1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphate (LPA(17:0)) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Milli-Q water was used throughout.

Yagi T., Kuschner C.E., Shoaib M., Choudhary R.C., Becker L.B., Lee A.T, & Kim J. (2019). Relative Ratios Enhance the Diagnostic Power of Phospholipids in Distinguishing Benign and Cancerous Ovarian Masses. Cancers, 12(1), 72.

+ Open protocol

+ Expand

Lipidomic Internal Standards Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt) (LPA 17:0), 1,2-dimyristoyl-sn-glycero-3-phosphate (sodium salt) (PA 14:0/14:0), N-lauroyl-d-erythrosphingosylphosphorylcholine (SM d18:1/12:0), 1-myristoyl-2-hydroxy-sn-glycero-3-phospho-(1 -rac-glycerol) (sodium salt) (LPG 14:0), 1,2-diheptadecanoyl-sn-glycero-3-phospho-(1 -rac-glycerol) (sodium salt) (PG 17:0/17:0), 1-nonadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine (LPC 19:0), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (PC 14:0/14:0), 1,2-dimyristoyl-sn-glycero-3-phospho-l-serine (sodium salt) (PS 14:0/14:0), 1-myristoyl-2-hydroxysn-glycero-3-phosphoethanolamine (LPE 14:0), and 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (PE 14:0/14:0) were purchased from Avanti Polar Lipids (Alabaster, USA) and used as internal standards (IS). Water, methanol, acetonitrile, ammonium formate (all LC-MS grade), n-hexane, and chloroform (HPLC grade) were purchased from VWR (Radnor, USA). LC-MS-grade 2-propanol was purchased from Fluka (Buchs, Switzerland) and acetone (GC-MS grade) was from MERCK (Darmstadt, Germany).

Berkecz R., Tömösi F., Körmöczi T., Szegedi V., Horváth J, & Janáky T. (2018). Comprehensive phospholipid and sphingomyelin profiling of different brain regions in mouse model of anxiety disorder using online two-dimensional (HILIC/RP)-LC/MS method. Journal of pharmaceutical and biomedical analysis, 149.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!